CUFinder

Rachel Abbotts

Rachel Abbotts

University of Maryland, Baltimore

H-index: 13

North America-United States

Contact Rachel Abbotts

About Rachel Abbotts

Rachel Abbotts, With an exceptional h-index of 13 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Maryland, Baltimore, specializes in the field of Radiation oncology, Lung cancer, Drug development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PR-005: ZNFX1 is a master regulator for epigenetic reprograming of mitochondrial inflammasome signaling and pathogen mimicry in cancer cells

DNMT inhibitor induces NSCLC inflammasome signaling and mitochondrial dysfunction, producing to DSB repair defects and PARP inhibitor sensitivity

Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use

PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers

Metastasis suppressor NME1 modulates choice of double-strand break repair pathways in melanoma cells by enhancing alternative NHEJ while inhibiting NHEJ and HR

Rachel Abbotts Information

University

Position

Research Associate

Citations(all)

1417

Citations(since 2020)

736

Cited By

976

hIndex(all)

13

hIndex(since 2020)

12

i10Index(all)

14

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Rachel Abbotts Skills & Research Interests

Radiation oncology

Lung cancer

Drug development

Top articles of Rachel Abbotts

Abstract PR-005: ZNFX1 is a master regulator for epigenetic reprograming of mitochondrial inflammasome signaling and pathogen mimicry in cancer cells

Cancer Research

2024/3/4

Rachel Abbotts
Rachel Abbotts

H-Index: 13

Sheng Liu
Sheng Liu

H-Index: 6

Jun Wan
Jun Wan

H-Index: 6

DNMT inhibitor induces NSCLC inflammasome signaling and mitochondrial dysfunction, producing to DSB repair defects and PARP inhibitor sensitivity

Cancer Research

2022/6/15

Rachel Abbotts
Rachel Abbotts

H-Index: 13

Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use

2022/5/26

Rachel Abbotts
Rachel Abbotts

H-Index: 13

PARP1 PARylates and stabilizes STAT5 in FLT3-ITD acute myeloid leukemia and other STAT5-activated cancers

Translational Oncology

2022/1/1

Rachel Abbotts
Rachel Abbotts

H-Index: 13

Mariusz Karbowski
Mariusz Karbowski

H-Index: 30

Metastasis suppressor NME1 modulates choice of double-strand break repair pathways in melanoma cells by enhancing alternative NHEJ while inhibiting NHEJ and HR

International Journal of Molecular Sciences

2020/8/17

Mary Leonard
Mary Leonard

H-Index: 1

Ying Wang
Ying Wang

H-Index: 3

Rachel Abbotts
Rachel Abbotts

H-Index: 13

Michal Zalzman
Michal Zalzman

H-Index: 8

See List of Professors in Rachel Abbotts University(University of Maryland, Baltimore)